List view / Grid view

Pedro Cutillas (Barts Cancer Institute)



Proteomics In-Depth Focus 2015

21 September 2015 | By , ,

In this Proteomics In-Depth Focus: David J. Britton & Pedro R. Cutillas from Barts Cancer Institute ask should LC-MS/MS proteomics guide targeted drug selection for cancer patients? And Manfred Raida from the National University of Singapore explains how mass spectrometry and drug development come together...